Tetrem Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,589,844
Closed -$50.7M 35
2017
Q2
$50.7M Sell
1,589,844
-27,827
-2% -$878K 2.21% 19
2017
Q1
$52.5M Sell
1,617,671
-45,411
-3% -$1.43M 2.16% 18
2016
Q4
$51.2M Sell
1,663,082
-155,786
-9% -$4.76M 2.05% 19
2016
Q3
$58.4M Sell
1,818,868
-56,973
-3% -$1.91M 2.2% 13
2016
Q2
$62.7M Sell
1,875,841
-20,132
-1% -$643K 2.43% 9
2016
Q1
$53.3M Buy
1,895,973
+237,052
+14% +$6.77M 2.1% 16
2015
Q4
$50.8M Buy
1,658,921
+770
+0% +$24.2K 2.02% 17
2015
Q3
$49.4M Sell
1,658,151
-39,693
-2% -$1.27M 1.68% 21
2015
Q2
$54M Sell
1,697,844
-195,617
-10% -$6.38M 1.66% 23
2015
Q1
$62.5M Buy
1,893,461
+276,860
+17% +$8.8M 1.91% 15
2014
Q4
$47.8M Buy
1,616,601
+1,607,946
+18,578% +$46.1M 1.35% 33
2014
Q3
$243K Buy
8,655
+455
+6% +$12.8K 0.01% 59
2014
Q2
$246K Buy
8,200
+982
+14% +$28K 0.01% 73
2014
Q1
$220K Buy
7,218
+802
+13% +$23.9K 0.01% 69
2013
Q4
$186K Buy
6,416
+872
+16% +$25.4K 0.01% 72
2013
Q3
$151K Buy
+5,544
New +$151K ﹤0.01% 65

Other funds holding PFE

Tetrem Capital Management's PFE Position: Q3 2017 in Review

Tetrem Capital Management sold out of Pfizer (PFE) in Q3 2017, closing a stake of 1,589,844 shares — an estimated $50.7M sold.

Tetrem Capital Management first reported a position in PFE in Q3 2013 and held it in 16 quarters. The position peaked at $62.7M in Q2 2016. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Tetrem Capital Management reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Tetrem Capital Management sold 1,589,844 Pfizer shares in Q3 2017, an estimated $50.7M.
  • Tetrem Capital Management first reported a position in Pfizer in Q3 2013 and held it in 16 quarters.
  • Tetrem Capital Management's Pfizer position peaked at $62.7M in Q2 2016.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Tetrem Capital Management's 13F filing for Q3 2017.